publication venue for
- Differentiating Neuroimaging and Clinical Outcomes Across Antithrombotic-Associated Intracerebral Hemorrhage 2019
- Effects of Rivaraoxaban vs. Aspirin on the Occurrence of Clinical and MRI- Defined Infarcts and Microbleeds in NAVIGATE ESUS – Results of NAVIGATE MIND MRI Substudy 2019
- Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban versus Aspirin by Risk Status: The NAVIGATE ESUS trial 2019
- What are the Causes of Recurrent Ischemic Stroke after Embolic Stroke of Undetermined Source (ESUS)? – Insights from the NAVIGATE-ESUS Trial 2019
- Computed Tomography Features and Outcomes of Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage Compared to Intracerebral Hemorrhage on Warfarin and ASA 2017
- Intensive Blood Pressure Lowering Does Not Increase the Risk of Diffusion-Weighted Imaging Hyperintense Lesions in Intracerebral Hemorrhage 2017
- Rivaroxaban for Secondary Prevention in Patients with Embolic Strokes of Undetermined Source: Design of the NAVIGATE ESUS Randomized Trial 2017
- Predictors of severe intracerebral hemorrhage expansion. 9:623-629. 2024
- Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trial.. 23969873241276358. 2024
- Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins.. 23969873241272530. 2024
- CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysis. 23969873241260538. 2024
- Association between blood pressure variability and outcomes after endovascular thrombectomy for acute ischemic stroke: An individual patient data meta-analysis. 9:88-96. 2024
- Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials. 8:106-116. 2023
- European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin.. 7:VI. 2022
- Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis. 7:92-98. 2022
- Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial. 6:222-228. 2021
- Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis. 6:62-71. 2021
- Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial. 1:146-154. 2016
- Age disparity in diagnostic evaluation of stroke patients: Embolic Stroke of Undetermined Source Global Registry Project. 1:130-138. 2016